Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteria, Anaerobic | 2 | 2019 | 68 | 1.250 |
Why?
|
| Intestines | 6 | 2019 | 1892 | 1.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2021 | 541 | 0.720 |
Why?
|
| Bacterial Infections | 2 | 2019 | 1395 | 0.690 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 246 | 0.630 |
Why?
|
| Tenericutes | 1 | 2017 | 2 | 0.600 |
Why?
|
| Caloric Restriction | 1 | 2019 | 289 | 0.580 |
Why?
|
| Microbiology | 1 | 2017 | 73 | 0.560 |
Why?
|
| Metagenome | 5 | 2017 | 421 | 0.500 |
Why?
|
| Growth and Development | 1 | 2014 | 48 | 0.490 |
Why?
|
| Probiotics | 4 | 2021 | 357 | 0.480 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2021 | 811 | 0.460 |
Why?
|
| Methylcellulose | 1 | 2012 | 36 | 0.430 |
Why?
|
| Phylogeny | 3 | 2017 | 2736 | 0.430 |
Why?
|
| Penicillins | 2 | 2017 | 393 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 6 | 2018 | 7222 | 0.390 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1059 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2018 | 992 | 0.320 |
Why?
|
| Dietary Fiber | 1 | 2012 | 754 | 0.320 |
Why?
|
| Obesity | 3 | 2014 | 12670 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1612 | 0.290 |
Why?
|
| Sex Factors | 1 | 2019 | 10279 | 0.260 |
Why?
|
| Mice | 18 | 2021 | 80087 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2019 | 3327 | 0.250 |
Why?
|
| Feces | 7 | 2021 | 1429 | 0.250 |
Why?
|
| Intestinal Mucosa | 3 | 2021 | 2987 | 0.220 |
Why?
|
| Helicobacter pylori | 2 | 2017 | 366 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 21529 | 0.220 |
Why?
|
| Helicobacter Infections | 2 | 2017 | 374 | 0.220 |
Why?
|
| Stomach | 2 | 2017 | 691 | 0.200 |
Why?
|
| Animals | 23 | 2021 | 166331 | 0.200 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2021 | 18 | 0.200 |
Why?
|
| Bifidobacterium | 2 | 2018 | 98 | 0.190 |
Why?
|
| Multiple Sclerosis | 3 | 2019 | 3132 | 0.180 |
Why?
|
| Nevada | 1 | 2019 | 22 | 0.170 |
Why?
|
| Prevotella | 1 | 2019 | 78 | 0.170 |
Why?
|
| Aquaporin 4 | 1 | 2020 | 157 | 0.170 |
Why?
|
| Microglia | 2 | 2018 | 1310 | 0.170 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 609 | 0.160 |
Why?
|
| Apyrase | 1 | 2021 | 368 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 17834 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8304 | 0.160 |
Why?
|
| Receptors, Chemokine | 1 | 2021 | 651 | 0.150 |
Why?
|
| Societies, Scientific | 1 | 2019 | 220 | 0.150 |
Why?
|
| Bacteria | 5 | 2017 | 2133 | 0.150 |
Why?
|
| Brain | 3 | 2021 | 26596 | 0.150 |
Why?
|
| Tennessee | 1 | 2017 | 117 | 0.150 |
Why?
|
| Fusobacterium necrophorum | 1 | 2017 | 14 | 0.140 |
Why?
|
| Base Composition | 1 | 2017 | 289 | 0.140 |
Why?
|
| Neuromyelitis Optica | 1 | 2020 | 257 | 0.140 |
Why?
|
| Fusobacterium Infections | 1 | 2017 | 53 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 1 | 2017 | 255 | 0.140 |
Why?
|
| Atrophy | 1 | 2021 | 1613 | 0.130 |
Why?
|
| Tylosin | 1 | 2015 | 3 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 750 | 0.130 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 1439 | 0.130 |
Why?
|
| Pharyngitis | 1 | 2017 | 217 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 1980 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 2389 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2018 | 543 | 0.120 |
Why?
|
| Somatosensory Cortex | 1 | 2018 | 519 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 536 | 0.120 |
Why?
|
| Body Weight | 3 | 2014 | 4590 | 0.120 |
Why?
|
| Amoxicillin | 1 | 2015 | 174 | 0.120 |
Why?
|
| Monocytes | 3 | 2018 | 2544 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 680 | 0.110 |
Why?
|
| Helminthiasis | 1 | 2014 | 81 | 0.110 |
Why?
|
| Inflammation | 1 | 2013 | 10592 | 0.110 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 158 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2020 | 1330 | 0.110 |
Why?
|
| Mouth | 1 | 2016 | 371 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2019 | 1006 | 0.110 |
Why?
|
| Cell Death | 1 | 2018 | 1654 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 1442 | 0.110 |
Why?
|
| Colitis | 2 | 2021 | 1209 | 0.110 |
Why?
|
| Homeostasis | 2 | 2021 | 3260 | 0.110 |
Why?
|
| Prebiotics | 1 | 2012 | 38 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 590 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2709 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2020 | 1332 | 0.100 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 457 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2016 | 800 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11839 | 0.090 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 382 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 1760 | 0.090 |
Why?
|
| Vagina | 1 | 2016 | 805 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 2686 | 0.090 |
Why?
|
| Mycobacterium | 1 | 2012 | 247 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 326 | 0.090 |
Why?
|
| Biodiversity | 1 | 2012 | 343 | 0.090 |
Why?
|
| Female | 20 | 2021 | 382109 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4703 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2017 | 1777 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2558 | 0.080 |
Why?
|
| Colon | 2 | 2017 | 1769 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2412 | 0.080 |
Why?
|
| Liver | 4 | 2019 | 7370 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2451 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2017 | 3423 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2016 | 1366 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2019 | 23112 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3742 | 0.070 |
Why?
|
| Humans | 21 | 2021 | 746044 | 0.070 |
Why?
|
| Lactobacillus | 2 | 2018 | 188 | 0.070 |
Why?
|
| Pregnancy | 4 | 2017 | 29294 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 3898 | 0.070 |
Why?
|
| Metabolome | 1 | 2012 | 948 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2015 | 2836 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2013 | 804 | 0.060 |
Why?
|
| Male | 16 | 2021 | 351093 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4861 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3742 | 0.060 |
Why?
|
| Adiposity | 1 | 2012 | 1822 | 0.050 |
Why?
|
| Skin | 1 | 2016 | 4390 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 1972 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2012 | 1860 | 0.050 |
Why?
|
| Diet | 2 | 2019 | 7881 | 0.040 |
Why?
|
| Lactase | 1 | 2019 | 71 | 0.040 |
Why?
|
| Quality of Life | 1 | 2021 | 12984 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9289 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2019 | 189 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2018 | 61 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11384 | 0.040 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 3784 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2018 | 104 | 0.040 |
Why?
|
| Plants | 1 | 2019 | 315 | 0.040 |
Why?
|
| Minocycline | 1 | 2018 | 168 | 0.040 |
Why?
|
| Lung | 1 | 2016 | 9842 | 0.040 |
Why?
|
| Adult | 6 | 2021 | 214958 | 0.030 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 57 | 0.030 |
Why?
|
| Streptococcus | 1 | 2017 | 197 | 0.030 |
Why?
|
| Methane | 1 | 2016 | 54 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8486 | 0.030 |
Why?
|
| Ataxia | 1 | 2018 | 304 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2020 | 2766 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 495 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 214412 | 0.030 |
Why?
|
| Bacteroides | 1 | 2016 | 164 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6058 | 0.030 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10018 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 291 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 820 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2019 | 751 | 0.030 |
Why?
|
| Lectins | 1 | 2016 | 480 | 0.030 |
Why?
|
| Helminths | 1 | 2014 | 38 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 107 | 0.030 |
Why?
|
| Cytokines | 2 | 2021 | 7219 | 0.030 |
Why?
|
| Fibrosis | 1 | 2021 | 2005 | 0.030 |
Why?
|
| India | 1 | 2020 | 2244 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 523 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2017 | 8370 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2016 | 1060 | 0.030 |
Why?
|
| Weaning | 1 | 2012 | 102 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 537 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2012 | 65 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 612 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 540 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 1156 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 567 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2012 | 96 | 0.030 |
Why?
|
| Metagenomics | 1 | 2015 | 432 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 706 | 0.020 |
Why?
|
| Cecum | 1 | 2012 | 230 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 3966 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 1905 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1853 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9310 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1822 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 555 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 1507 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21673 | 0.020 |
Why?
|
| Genetic Fitness | 1 | 2012 | 115 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1404 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 14113 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1570 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 1443 | 0.020 |
Why?
|
| Infant | 3 | 2017 | 35444 | 0.020 |
Why?
|
| Phenotype | 2 | 2017 | 16245 | 0.020 |
Why?
|
| Bone Development | 1 | 2012 | 472 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2017 | 41376 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9441 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 915 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 502 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 5835 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4858 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1853 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14211 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3709 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3011 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 57106 | 0.020 |
Why?
|
| Internet | 1 | 2017 | 3037 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15631 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6459 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3609 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11036 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6453 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1875 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4480 | 0.010 |
Why?
|
| Child | 3 | 2017 | 78456 | 0.010 |
Why?
|
| Adolescent | 3 | 2017 | 86202 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3017 | 0.010 |
Why?
|
| Cholesterol | 1 | 2012 | 2879 | 0.010 |
Why?
|
| Body Composition | 1 | 2012 | 2381 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5652 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15308 | 0.010 |
Why?
|
| Bone Density | 1 | 2012 | 3510 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25752 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18146 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53218 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29614 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_